Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 4/20 | 0.95 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.95 |
| ▸ | HTT | P42858 | 2/20 | 0.95 |
| ▸ | THRB | P10828 | 1/20 | 0.95 |
| ▸ | MAPT | P10636 | 1/20 | 0.95 |
| ▸ | TSHR | P16473 | 3/20 | 0.80 |
| ▸ | USP2 | O75604 | 2/20 | 0.54 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.53 |
| ▸ | LMNA | P02545 | 3/20 | 0.52 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.52 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.52 |
| ▸ | CES2 | O00748 | 2/20 | 0.52 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.49 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.49 |
| ▸ | CASP1 | P29466 | 1/20 | 0.49 |
| ▸ | SLCO1B3 | Q9NPD5 | 1/20 | 0.49 |
| ▸ | SLCO1B1 | Q9Y6L6 | 1/20 | 0.49 |
| ▸ | CES1 | P23141 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21828760 | 1.00 | MEN1 (0.95) | MEN1KMT2AHTTTHRBMAPT | |
| SCHEMBL344085 | 1.00 | MEN1 (0.95) | MEN1KMT2AHTTTHRBMAPT | |
| Di(Hydroxyethyl)Ether SCHEMBL2484145 | 1.00 | MEN1 (0.95) | MEN1KMT2AHTTTHRBMAPT | |
| Di(Hydroxyethyl)Ether SCHEMBL23356733 | 1.00 | MEN1 (0.95) | MEN1KMT2AHTTTHRBMAPT | |
| Di(Hydroxyethyl)Ether SCHEMBL23356816 | 1.00 | MEN1 (0.95) | MEN1KMT2AHTTTHRBMAPT | |
| Di(Hydroxyethyl)Ether SCHEMBL23356871 | 1.00 | MEN1 (0.95) | MEN1KMT2AHTTTHRBMAPT | |
| Di(Hydroxyethyl)Ether SCHEMBL23356793 | 1.00 | MEN1 (0.95) | MEN1KMT2AHTTTHRBMAPT | |
| Di(Hydroxyethyl)Ether SCHEMBL23356787 | 1.00 | MEN1 (0.95) | MEN1KMT2AHTTTHRBMAPT | |
| SCHEMBL185805 | 1.00 | MEN1 (0.95) | MEN1KMT2AHTTTHRBMAPT | |
| Di(Hydroxyethyl)Ether SCHEMBL2124090 | 1.00 | MEN1 (0.95) | MEN1KMT2AHTTTHRBMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 45 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260060240-A1 | METHOD OF DEPRESSING VOLATILITY OF ORGANIC SOLUTES FROM THEIR AQUEOUS SOLUTIONS | VIVE CROP PROT INC (CA) | 2026-03-05 | — | — | US | claimed |
| US-20260060240-A1 | METHOD OF DEPRESSING VOLATILITY OF ORGANIC SOLUTES FROM THEIR AQUEOUS SOLUTIONS | VIVE CROP PROT INC (CA) | 2026-03-05 | — | — | US | disclosed |
| CN-119367342-A | CYP-eicosanoids analogs for treating or preventing diseases associated with neovascularization and/or inflammation | 奥迈科斯治疗公司 | 2025-01-28 | — | — | CN | disclosed |
| CN-113717154-B | Methods for treating huntington's disease | PTC医疗公司 | 2024-11-15 | — | — | CN | disclosed |
| US-20240360163-A1 | Nucleoside Prodrugs and Uses Related Thereto | UNIV EMORY (US) | 2024-10-31 | — | — | US | disclosed |
| CN-118613480-A | Polycyclic IRAK and FLT3 inhibiting compounds and uses thereof | 儿童医院医学中心 | 2024-09-06 | — | — | CN | disclosed |
| US-12049474-B2 | Nucleoside prodrugs and uses related thereto | EMORY UNIVERSITY (US) | 2024-07-30 | — | — | US | disclosed |
| CN-117794939-A | Antibiotic pyrazinothiazine derivatives and process for their preparation | 巴格沃克斯研究印度私人有限公司 | 2024-03-29 | — | — | CN | disclosed |
| CN-110946865-B | Methods for treating huntington's disease | PTC医疗公司 | 2024-01-26 | — | — | CN | disclosed |
| CN-117015380-A | Polycyclic IRAK and flt3 inhibiting compounds and uses thereof | 儿童医院医学中心 | 2023-11-07 | — | — | CN | disclosed |
| CN-100371398-C | Articles having a photochromic polymeric coating | PPG IND OHIO INC (US) | 2008-02-27 | — | — | CN | disclosed |
| CN-101056650-A | Stable formulations of insulinotropic peptides | NOVO NORDISK AS (DK) | 2007-10-17 | — | — | CN | disclosed |
| CN-1281705-C | Photochromic polymerizable compositions | PPG IND OHIO INC (US) | 2006-10-25 | — | — | CN | disclosed |
| EP-1058274-B1 | Composition for film formation and material for insulating film formation | JSR CORP (JP) | 2005-07-27 | — | — | EP | disclosed |
| CN-1596291-A | Photochromic polymerizable compositions | PPG IND OHIO INC (US) | 2005-03-16 | — | — | CN | disclosed |
| CN-1596289-A | article having a photochromic polymeric coating | PPG IND OHIO INC (US) | 2005-03-16 | — | — | CN | disclosed |
| US-6376634-B1 | ORGANOSILICON POLYMERS | JSR CORPORATION (JP) | 2002-04-23 | — | — | US | disclosed |
| EP-1058274-A1 | Composition for film formation and material for insulating film formation | JSR Corporation (JP) | 2000-12-06 | — | — | EP | disclosed |
| EP-0025720-B1 | PROCESS FOR THE MANUFACTURE OF MIXED PHOSPHORIC ACID ESTER COMPOSITIONS AND PLASTICISED POLYMERS CONTAINING THEM | FMC Corporation (US) | 1986-02-26 | — | — | EP | disclosed |
| EP-0025720-A1 | Process for the manufacture of mixed phosphoric acid ester compositions and plasticised polymers containing them | FMC Corporation (US) | 1981-03-25 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260060240-A1 | METHOD OF DEPRESSING VOLATILITY OF ORGANIC SOLUTES FROM THEIR AQUEOUS SOLUTIONS | MYB, DRD1, SFN | MEN1 4484/4885KMT2A 2694/4885HTT 2253/4885 |
| US-20240360163-A1 | Nucleoside Prodrugs and Uses Related Thereto | PNPO, GSTO1, CYP2C18 | MEN1 4325/4885KMT2A 3065/4885HTT 3975/4885 |
| US-12049474-B2 | Nucleoside prodrugs and uses related thereto | PNPO, GSTO1, CYP2C18 | MEN1 4325/4885KMT2A 3065/4885HTT 3975/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.